SCHEMBL1268596

SCHEMBL1268596

CC(=O)C1=CC=CN(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468058 0.83 TSHR (0.37)
SCHEMBL28702490 0.83 TSHR (0.37)
Iodide SCHEMBL10567947 0.82 TSHR (0.36)
Water SCHEMBL28685341 0.82 TSHR (0.36)
Fluoride SCHEMBL22206791 0.80 TSHR (0.32)
Hydrochloric Acid SCHEMBL134284 0.80 THRB (0.34)
Bromide SCHEMBL22206792 0.80 TSHR (0.32)
SCHEMBL3449675 0.79 BAZ2B (0.33)
SCHEMBL12562736 0.79
SCHEMBL27531014 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114689-A1 NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS CORTRIA CORPORATION (US) 2012-05-10 US claimed
US-20080112968-A1 NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS DERMENA (CA) 2008-05-15 US claimed
US-8377972-B2 Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection Trigendo Sp. zo.o. (PL) 2013-02-19 US disclosed
CN-102127009-B Substituted pyridine ionic liquid and application thereof SINOCHEM CORP 2012-08-29 CN disclosed
EP-2124946-B1 THE USE OF N-METHYL PYRIDINIUM DERIVATIVES FOR HEPATOPROTECTION HEPENDO SP Z O O (PL) 2012-05-23 EP disclosed
US-20120114689-A1 NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS CORTRIA CORPORATION (US) 2012-05-10 US disclosed
CN-102127009-A Substituted pyridine ionic liquid and application thereof SINOCHEN CORP 2011-07-20 CN disclosed
US-20110118316-A1 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection TRIGENDO SP. Z O.O. (PL) 2011-05-19 US disclosed
US-7893095-B2 Treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury; 1,4-dimethylpyridinium Chloride; diabetes, metabolic syndrome, atherosclerosis TRIGENDO SP. Z O.O. (PL) 2011-02-22 US disclosed
CN-1905875-B The use of quaternary pyridinium salts as vasoprotective agents PHARMENA SP Z O O 2010-07-28 CN disclosed
EP-2181704-A2 Drug delivery from rapid gelling polymer composition ANGIOTECH INTERNATIONAL AG (CH) 2010-05-05 EP disclosed
WO-2008062324-A2 COMPOSITIONS COMPRISING NICOTINAMIDE AND WAKAME EXTRACT HAVING SKIN ANTI-AGING PROPERTIES DERMENA (CA) 2008-05-29 WO disclosed
US-20080112968-A1 NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS DERMENA (CA) 2008-05-15 US disclosed
CN-1905875-A The use of quaternary pyridinium salts as vasoprotective agents PHARMENA SP Z O O (PL) 2007-01-31 CN disclosed